Viatris' (VTRS) Q4 Earnings Miss, Biocon Biologics Deal Inked

Published on February 28, 2022

Viatris (VTRS) misses on Q4 earnings but surpasses sales estimates. The company announces a combination of its biosimilars portfolio with Biocon Biologics.

Continue reading on website
Other news

The Only 3 Auto Manufacturers Trading Higher in 2022: Vicinity, Honda, and Blue Bird

February 28, 2022
A semiconductor shortage, production shutdowns, and other pandemic-led headwinds have negatively impacted the automotive industry. In addition, escalating geopolitical tensions and looming interest rate increases have further exacerbated the sector's...

Berkshire (BRK.B) Q4 Earnings Up on Strong Segment Results

February 28, 2022
Berkshire (BRK.B) Q4 results reflect solid performance in Railroad, Utilities and Energy as well as Manufacturing, Service and Retailing.